KKR closing on $5bn pharma exit

KKR is close to selling capsule maker Capsugel to Swiss drug maker Lonza for more than $5bn.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this